These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2327666)

  • 21. [Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience].
    Derwich K; Wachowiaki J; Kaczmarek-Kanoldi M; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Jackowska T; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Cwiklińska M; Kołtan A; Malinowska I; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A;
    Przegl Lek; 2006; 63(1):7-10. PubMed ID: 16892891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of testicular biopsy after cessation of maintenance chemotherapy in childhood acute lymphoblastic leukemia: a report from the Children's Cancer and Leukemia Study Group.
    Koizumi S; Shimizu H; Asami K; Utsumi J; Ariyoshi N; Watanabe A; Ninomiya T; Takaue Y; Matsumoto K; Nishikawa K
    Int J Hematol; 1994 Aug; 60(2):137-43. PubMed ID: 7948963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
    Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
    Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
    Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
    Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute lymphoblastic leukemia in Burkitt cells: clinical, therapeutic and prognostic aspects].
    Vassal G; Leverger G; Schaison G; Castaigne S
    Nouv Rev Fr Hematol (1978); 1986; 28(3):141-6. PubMed ID: 3489222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
    Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results and complications of induction treatment of acute leukemia in children. A personal series of 79 cases (1988-1989)].
    Regaieg R; Bertrand Y; Mardini R; Manel AM; Berthier JC; Magaud JP; Charrin C; Barbe G; Souillet G; Philippe N
    Pediatrie; 1992; 47(1):47-53. PubMed ID: 1337777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor prognosis in children with acute nonlymphoblastic leukemia in Turkey.
    Hiçsönmez G; Gürgey A; Zamani VP; Yetgin S; Altay C; Ozsoylu S
    Am J Pediatr Hematol Oncol; 1988; 10(3):268-72. PubMed ID: 3177815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Our experiences in the treatment of acute leukemias in children].
    Stojimirović E; Cvetković P
    Bilt Hematol Transfuz; 1976; 4(1-2):55-62. PubMed ID: 182115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and prognostic implications of bone lesions in childhood leukemia at diagnosis.
    Kai T; Ishii E; Matsuzaki A; Okamura J; Ikuno Y; Tasaka E; Ueda K
    Leuk Lymphoma; 1996 Sep; 23(1-2):119-23. PubMed ID: 9021694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.
    Quintana J; Advis P; Becker A; Beresi V; Campbell M; Vinés EF; García H; Salgado C; Vargas L; Rojas J; Obando M; Neira L; Páez E; Zolezzi P
    Leukemia; 2005 Dec; 19(12):2143-6. PubMed ID: 16304574
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prognosis for the development of resistance to cytostatics in leukosis cells during induction therapy in acute non-lymphoblastic leukosis: a regression model].
    Popović SL
    Med Pregl; 1991; 44(11-12):451-6. PubMed ID: 1821441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.